- Home
- NGNE vs NVRO Comparison
NGNE vs NVRO Comparison
Compare NGNE & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- NVRO
- Stock Information
- Founded
- NGNE 2003
- NVRO 2006
- Country
- NGNE United States
- NVRO United States
- Employees
- NGNE N/A
- NVRO N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- NVRO Medical/Dental Instruments
- Sector
- NGNE Health Care
- NVRO Health Care
- Exchange
- NGNE Nasdaq
- NVRO Nasdaq
- Market Cap
- NGNE 230.0M
- NVRO 214.2M
- IPO Year
- NGNE N/A
- NVRO 2014
- Fundamental
- Price
- NGNE $17.36
- NVRO $5.73
- Analyst Decision
- NGNE Strong Buy
- NVRO Hold
- Analyst Count
- NGNE 6
- NVRO 12
- Target Price
- NGNE $60.80
- NVRO $7.24
- AVG Volume (30 Days)
- NGNE 277.9K
- NVRO 1.7M
- Earning Date
- NGNE 11-18-2024
- NVRO 02-28-2025
- Dividend Yield
- NGNE N/A
- NVRO N/A
- EPS Growth
- NGNE N/A
- NVRO N/A
- EPS
- NGNE N/A
- NVRO N/A
- Revenue
- NGNE $925,000.00
- NVRO $419,146,000.00
- Revenue This Year
- NGNE N/A
- NVRO N/A
- Revenue Next Year
- NGNE N/A
- NVRO $0.23
- P/E Ratio
- NGNE N/A
- NVRO N/A
- Revenue Growth
- NGNE N/A
- NVRO N/A
- 52 Week Low
- NGNE $14.42
- NVRO $3.17
- 52 Week High
- NGNE $74.49
- NVRO $16.12
- Technical
- Relative Strength Index (RSI)
- NGNE 44.25
- NVRO 70.16
- Support Level
- NGNE $16.72
- NVRO $4.77
- Resistance Level
- NGNE $19.97
- NVRO $5.80
- Average True Range (ATR)
- NGNE 2.39
- NVRO 0.13
- MACD
- NGNE 0.08
- NVRO -0.01
- Stochastic Oscillator
- NGNE 19.43
- NVRO 93.20
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.